MedTrace Logo

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

NCT06178822 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3300

Last updated 2025-10-02

No results posted yet for this study

Summary

Objectives:

1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection.
2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis.
3. To determine the long term cognitive and physical sequelae of sepsis after admission.

Conditions

  • Sepsis
  • Septic Shock
  • Sepsis, Severe
  • Infections
  • Infection Viral
  • Infection, Bacterial
  • Infections, Respiratory

Interventions

OTHER

No intervention

There is no intervention

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Flevoziekenhuis

    collaborator OTHER

  • Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

    lead OTHER

Principal Investigators

  • Willem Joost Wiersinga, MD, PhD · Amsterdam UMC, location AMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06178822 on ClinicalTrials.gov